Pharma & Biotech
ANGLE’s Parsortix liquid biopsy proving to be more than just a cancer detection device
Verona Pharma looks forward to phase III ensifentrine trials after US$200mln fundraise
Amphion Innovations now private after AIM de-listing
Only registered members can use this feature.
© Proactive 2021.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.